We have found 46587 results matching your criteria.
Please wait while we search...

General Material Information

Preferred name alpha-santalol
Trivial Name (+)-α-Santalol
Short Description 12-alpha-santalen-14-ol
Formula C15 H24 O
CAS Number 115-71-9
Deleted CAS Number 14490-13-2
FEMA Number 3006
Flavis Number 2.217
ECHA Number 204-102-8
FDA UNII 15X09F2755
Nikkaji Number J2.898.383B
COE Number 74
xLogP3-AA 4.00 (est)
NMR Predictor External link
FDA Patent No longer provide for the use of these seven synthetic flavoring substances
FDA Mainterm 115-71-9 ; SANTALOL, ALPHA
Synonyms
  • alpha- argeol
  • arheol
  • (Z)-alpha-5-(2,3-dimethyl tricyclo(2.2.1.0(2,6))hept-3-yl)-2-methyl-2-penten-1-ol
  • (Z)-alpha-5-(2,3-dimethyl tricyclo(2.2.1.02,6)hept-3-yl)-2-methyl-2-penten-1-ol stereoisomer
  • 12-alpha- santalen-14-ol
  • (Z)-alpha- santalol
  • cis-alpha- santalol
  • (E)-5-(2,3-dimethyl-4,5,6,7-tetrahydro-1H-tricyclo[2.2.1.02,6]heptan-3-yl)-2-methylpent-2-en-1-ol
  • 2-Penten-1-ol, 5-[(1R,3R,6S)-2,3-dimethyltricyclo[2.2.1.02,6]hept-3-yl]-2-methyl-, (2Z)-
  • 2-Penten-1-ol, 5-(2,3-dimethyltricyclo[2.2.1.02,6]hept-3-yl)-2-methyl-, [R(Z)]-
  • α-Santalol
  • 2-Penten-1-ol, 5-(2,3-dimethyltricyclo[2.2.1.02,6]hept-3-yl)-2-methyl-, stereoisomer
  • Tricyclo[2.2.1.02,6]heptane, 2-penten-1-ol deriv.
  • (2Z)-5-[(1R,3R,6S)-2,3-Dimethyltricyclo[2.2.1.02,6]hept-3-yl]-2-methyl-2-penten-1-ol
  • Santalol a
  • Sandal
  • (+)-α-Santalol
  • cis-α-Santalol
  • d-α-Santalol
  • (Z)-α-Santalol
  • (+)-(Z)-α-Santalol

US / EU / FDA / JECFA / FEMA / Scholar / Patents

Google Scholar Start search
Google Books Start search
Google Patents Start search
Perfumer & Flavorists Start search
EU Patents Start search
PubMeb Start search
NCBI Start search

Literature & References

(E)-5-(2,3-dimethyl-4,5,6,7-tetrahydro-1H-tricyclo[2.2.1.02,6]heptan-3-yl)-2-methylpent-2-en-1-ol
NIST Chemistry WebBook:Search Inchi
Canada Domestic Sub. List:115-71-9
Pubchem (cid):5368797
Pubchem (sid):134975037
Publications by PubMed
Relationship Between Emotional Behavior in Mice and the Concentration of (+)-α-Santalol in the Brain.
Suppression of lipopolysaccharide-stimulated cytokine/chemokine production in skin cells by sandalwood oils and purified α-santalol and β-santalol.
Biocatalyst mediated regio- and stereo-selective hydroxylation and epoxidation of (Z)-α-santalol.
α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway.
α-Santalol, a skin cancer chemopreventive agent with potential to target various pathways involved in photocarcinogenesis.
Chemopreventive effects of combination of honokiol and magnolol with α-santalol on skin cancer developments.
Antineoplastic effects of α-santalol on estrogen receptor-positive and estrogen receptor-negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis.
Structural factors in the odor of alpha-santalol derivatives.
Evaluation of in vivo anti-hyperglycemic and antioxidant potentials of α-santalol and sandalwood oil.
α-Santalol, a derivative of sandalwood oil, induces apoptosis in human prostate cancer cells by causing caspase-3 activation.
Structure-odor relationships of α-santalol derivatives with modified side chains.
α-Santalol derivatives from Santalum album and their cytotoxic activities.
Determination of the absolute stereochemistry of limonene and alpha-santalol by Raman optical activity spectroscopy.
Alpha-santalol, a chemopreventive agent against skin cancer, causes G2/M cell cycle arrest in both p53-mutated human epidermoid carcinoma A431 cells and p53 wild-type human melanoma UACC-62 cells.
Skin cancer chemoprevention by α-santalol.
Molecular regulation of santalol biosynthesis in Santalum album L.
endo/exo stereoselectivity in Diels-Alder reactions of α,β-dialkylated conjugated enals to cyclic 1,3-dienes: intermediates in the synthesis of (-)-β-santalol and its analogs.
Repellent effect of santalol from sandalwood oil against Tetranychus urticae (Acari: Tetranychidae).
Structure-odor relationships of semisynthetic β-santalol analogs.
Anticancer Effects of Sandalwood (Santalum album).
Acaricidal and oviposition deterring effects of santalol identified in sandalwood oil against two-spotted spider mite, Tetranychus urticae Koch (Acari: Tetranychidae).
In vitro anti-viral effect of β-santalol against influenza viral replication.
Skin cancer chemopreventive agent, {alpha}-santalol, induces apoptotic death of human epidermoid carcinoma A431 cells via caspase activation together with dissipation of mitochondrial membrane potential and cytochrome c release.
A rare type of sesquiterpene and β-santalol derivatives from Santalum album and their cytotoxic activities.
Chemoprevention by alpha-santalol on UVB radiation-induced skin tumor development in mice.
Effects of alpha-santalol on proapoptotic caspases and p53 expression in UVB irradiated mouse skin.
Chemopreventive effects of various concentrations of alpha-santalol on skin cancer development in CD-1 mice.
Chemopreventive effects of alpha-santalol on ultraviolet B radiation-induced skin tumor development in SKH-1 hairless mice.
Chemopreventive effects of alpha-santalol on skin tumor development in CD-1 and SENCAR mice.
A novel chemopreventive mechanism for a traditional medicine: East Indian sandalwood oil induces autophagy and cell death in proliferating keratinocytes.
East Indian Sandalwood and alpha-santalol odor increase physiological and self-rated arousal in humans.
The transcriptome of sesquiterpenoid biosynthesis in heartwood xylem of Western Australian sandalwood (Santalum spicatum).
Fragrance material review on alpha-santalol.
Evaluation of the effects of East Indian sandalwood oil and alpha-santalol on humans after transdermal absorption.
Hawaiian sandalwood: oil composition of Santalum paniculatum and comparison with other sandal species.
Preparative separation of α- and β-santalenes and (Z)-α- and (Z)-β-santalols using silver nitrate-impregnated silica gel medium pressure liquid chromatography and analysis of sandalwood oil.
TLC-bioautographic evaluation of in vitro anti-tyrosinase and anti-cholinesterase potentials of sandalwood oil.
Effect of α-santalol and β-santalol from sandalwood on the central nervous system in mice.
(13)C-NMR spectra of santalol derivatives: a comparison of DFT-based calculations and database-oriented prediction techniques.
The synthesis of (Z)-trisubstituted allylic alcohols by the selective 1,4-hydrogenation of dienol esters: improved synthesis of (-)-β-santalol.
Effects of sesquiterpenoids from "Oriental incenses" on acetic acid-induced writhing and D2 and 5-HT2A receptors in rat brain.
Geographic and phenotypic variation in heartwood and essential-oil characters in natural populations of Santalum austrocaledonicum in Vanuatu.
[Effect of santalol on the sleep-wake cycle in sleep-disturbed rats].
Fragrance material review on santalol.
Structure-activity relationships of sandalwood odorants: synthesis and odour of methyl-beta-santalol.
Syntheses and odor of "bulky group"-modified sandalwood odorants: isophorono-beta-santalol analogues.
Structure-activity relationships of sandalwood odorants: total synthesis and fragrance properties of cyclopropano-beta-santalol.
Synthesis and olfactoric activity of side-chain modified beta-santalol analogues.
Enantioselective synthesis of (-)-beta-santalol by a copper-catalyzed enynol cyclization-fragmentation reaction.
Antimicrobial activity and chemical composition of endemic Centaurea cariensis subsp. niveo-tomentosa.
[Preparation of santalol by centrifugal-thin layer chromatographic method].
Structure-activity relationships of sandalwood odorants: synthesis and odor of tricyclo beta-santalol.
Biosynthesis of Sandalwood Oil: Santalum album CYP76F cytochromes P450 produce santalols and bergamotol.
Chemical composition of the essential oils of Clausena lansium from Hainan Island, China.
Chemical composition of volatile oils from the pericarps of Indian sandalwood (Santalum album) by different extraction methods.
α- and β-Santalols Directly Interact with Tubulin and Cause Mitotic Arrest and Cytotoxicity in Oral Cancer Cells.
Transcriptional upregulation of Nrf2-dependent phase II detoxification genes in the involved epidermis of vitiligo vulgaris.
Anti-Helicobacter pylori compounds from Santalum album.
In the quest for a virtual pseudo receptor for sandalwood-like odorants. Part I: The empirical approach.
Comprehensive two-dimensional gas chromatography with flame ionization and time-of-flight mass spectrometry detection: qualitative and quantitative analysis of West Australian sandalwood oil.
Evaluation of the quality of sandalwood essential oils by gas chromatography-mass spectrometry.
Analysis of fragrance compounds in blood samples of mice by gas chromatography, mass spectrometry, GC/FTIR and GC/AES after inhalation of sandalwood oil.
Biotransformation of terpenoids by mammals, microorganisms, and plant-cultured cells.
Safety assessment of sandalwood oil (Santalum album L.).
Synthesis of new exo- and endo-3,8-dihydro-beta-santalols and other norbornyl-derived alcohols.
Comparative phytochemical analysis and antibacterial efficacy of in vitro and in vivo extracts from East Indian sandalwood tree (Santalum album L.).
Application of a multidimensional gas chromatography system with simultaneous mass spectrometric and flame ionization detection to the analysis of sandalwood oil.
Structure-activity relationships of sandalwood odorants: synthesis of a new campholene derivative.
Synthesis and olfactory evaluation of bulky moiety-modified analogues to the sandalwood odorant Polysantol.
[The influence of external stimulation on content and quality of volatile oil in Lignun Santali albi].
6-Substituted indanoyl isoleucine conjugate induces tobacco plant responses in secondary metabolites.
Essential oil composition of three Peperomia species from the Amazon, Brazil.
Recent developments in the chemistry of sandalwood odorants.
Depigmented contact dermatitis due to incense.
Comparative molecular and phytochemical study of the tree species Santalum austrocaledonicum (Santalaceae) distributed in the New-Caledonian archipelago.
Composition, antimicrobial activity and cytotoxicity of essential oils from Aristolochia mollissima.
Broad activation of the glomerular layer enhances subsequent olfactory responses.
Microbiological transformations of terpenes. III. Transformations of some mono- and sesqui-terpenes.

Other Information

(IUPAC):Atomic Weights of the Elements 2011 (pdf)
Videos:The Periodic Table of Videos
tgsc:Atomic Weights use for this web site
(IUPAC):Periodic Table of the Elements
FDA Substances Added to Food (formerly EAFUS):View
CHEBI:View
KEGG (GenomeNet):C09719
HMDB (The Human Metabolome Database):HMDB34940
FooDB:FDB013533
Typical G.C.
VCF-Online:VCF Volatile Compounds in Food
ChemSpider:View
Wikipedia:View

PhysChem Properties

Material listed in food chemical codex No
Molecular weight 220.35548400879
Specific gravity @ 25 °C
Pounds per Gallon 8.03 to 8.113
Refractive Index 1.498 to 1.509 @ 20 °C
Boiling Point 159 to 160°C @ 10 mm Hg
Vapor Pressure 0.000118 mmHg @ 25 °C
Flash Point TCC Value 138.33 °C TCC
logP (o/w) 4.53 est
Solubility
alcohol Yes
water, 6.414 mg/L @ 25 °C (est) Yes
water No

Organoleptic Properties

Odor Type: Woody
woody, sandalwood
General comment At 100.00 %. woody sandalwood

Occurrences

Safety Information

Safety information

Hazards identification
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
Pictogram
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
oral-rat LD50 3800 mg/kg
Food and Cosmetics Toxicology. Vol. 12, Pg. 991, 1974.

Dermal Toxicity:
skin-rabbit LD50 > 5000 mg/kg
Food and Cosmetics Toxicology. Vol. 12, Pg. 991, 1974.

Inhalation Toxicity:
Not determined

Safety in use information

Category:
flavor and fragrance agents
RIFM Fragrance Material Safety Assessment: Search
IFRA Code of Practice Notification of the 49th Amendment to the IFRA Code of Practice
maximum skin levels for fine fragrances:
0.1000 % and are based on the assumption that the fragrance mixture is used at 20% in a consumer product (IFRA Use Level Survey).(IFRA, 2004)
Recommendation for alpha-santalol usage levels up to:
4.0000 % in the fragrance concentrate.
use level in formulae for use in cosmetics:
0.1500 %
Dermal Systemic Exposure in Cosmetic Products:
0.0038 mg/kg/day (IFRA, 2004)
Maximised Survey-derived Daily Intakes (MSDI-EU): 0.11 (μg/capita/day)
Modified Theoretical Added Maximum Daily Intake (mTAMDI): 3900 (μg/person/day)
Threshold of Concern:1800 (μg/person/day)
Structure Class: I
Use levels for FEMA GRAS flavoring substances on which the FEMA Expert Panel based its judgments that the substances are generally recognized as safe (GRAS).
The Expert Panel also publishes separate extensive reviews of scientific information on all FEMA GRAS flavoring substances and can be found at FEMA Flavor Ingredient Library
publication number: 3
Click here to view publication 3
average usual ppmaverage maximum ppm
baked goods: 1.000008.00000
beverages(nonalcoholic): 0.060002.00000
beverages(alcoholic): --
breakfast cereal: --
cheese: --
chewing gum: -0.20000
condiments / relishes: --
confectionery froastings: --
egg products: --
fats / oils: --
fish products: --
frozen dairy: 0.350002.00000
fruit ices: 0.350002.00000
gelatins / puddings: --
granulated sugar: --
gravies: --
hard candy: 1.0000010.00000
imitation dairy: --
instant coffee / tea: --
jams / jellies: --
meat products: --
milk products: --
nut products: --
other grains: --
poultry: --
processed fruits: --
processed vegetables: --
reconstituted vegetables: --
seasonings / flavors: --
snack foods: --
soft candy: --
soups: --
sugar substitutes: --
sweet sauces: --
Food categories according to Commission Regulation EC No. 1565/2000 (EC, 2000) in FGE.06 (EFSA, 2002a). According to the Industry the "normal" use is defined as the average of reported usages and "maximum use" is defined as the 95th percentile of reported usages (EFSA, 2002i).
Note: mg/kg = 0.001/1000 = 0.000001 = 1/1000000 = ppm.
average usage mg/kgmaximum usage mg/kg
Dairy products, excluding products of category 02.0 (01.0): 7.0000035.00000
Fats and oils, and fat emulsions (type water-in-oil) (02.0): 5.0000025.00000
Edible ices, including sherbet and sorbet (03.0): 10.0000050.00000
Processed fruit (04.1): 7.0000035.00000
Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds (04.2): --
Confectionery (05.0): 10.0000050.00000
Chewing gum (05.3): --
Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, excluding bakery (06.0): 5.0000025.00000
Bakery wares (07.0): 10.0000050.00000
Meat and meat products, including poultry and game (08.0): 2.0000010.00000
Fish and fish products, including molluscs, crustaceans and echinoderms (MCE) (09.0): 2.0000010.00000
Eggs and egg products (10.0): 2.0000010.00000
Sweeteners, including honey (11.0): 2.0000010.00000
Salts, spices, soups, sauces, salads, protein products, etc. (12.0): 5.0000025.00000
Foodstuffs intended for particular nutritional uses (13.0): 10.0000050.00000
Non-alcoholic ("soft") beverages, excl. dairy products (14.1): 5.0000025.00000
Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts (14.2): 10.0000050.00000
Ready-to-eat savouries (15.0): 20.00000100.00000
Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed in categories 01.0 - 15.0 (16.0): 5.0000025.00000

Safety references

European Food Safety Athority(EFSA):Flavor usage levels; Subacute, Subchronic, Chronic and Carcinogenicity Studies; Developmental / Reproductive Toxicity Studies; Genotoxicity Studies...

European Food Safety Authority (EFSA) reference(s):

Scientific Opinion on Flavouring Group Evaluation 207 (FGE.207): Consideration of genotoxic potential for one branched-chain aliphatic acyclic a,ß-unsaturated 2-alkylated aldehyde with additional double-bonds, from subgroup 1.1.2 of FGE.19 and four alicyclic aldehydes with the a,ß-unsaturation in a side-chain, from subgroup 2.1 of FGE.19, which are considered to be covered by the one substance of subgroup 1.1.2, by EFSA
View page or View pdf

Scientific Opinion on Flavouring Group Evaluation 73, Revision 2 (FGE.73Rev2): Consideration of alicyclic primary alcohols, aldehydes, acids and related esters evaluated by JECFA (59th meeting) structurally related to primary saturated or unsaturated alicyclic alcohols, aldehydes, acids and esters evaluated by EFSA in FGE.12Rev3 (2012)
View page or View pdf

Scientific Opinion on Flavouring Group Evaluation 12, Revision 4 (FGE.12Rev4): primary saturated or unsaturated alicyclic alcohols, aldehydes, acids and esters from chemical groups 1 and 7
View page or View pdf

Scientific Opinion on Flavouring Group Evaluation 72, Revision 1 (FGE.72Rev1): Consideration of aliphatic, branched-chain saturated and unsaturated alcohols, aldehydes, acids, and related esters evaluated by the JECFA (61st meeting) structurally related to branched- and straight-chain unsaturated carboxylic acids, esters of these and straight-chain aliphatic saturated alcohols evaluated by EFSA in FGE.05Rev2
View page or View pdf

Scientific Opinion on Flavouring Group Evaluation 12, Revision 5 (FGE.12Rev5): Primary saturated or unsaturated alicyclic alcohol, aldehyde, acid, and esters from chemical groups 1, 7 and 8)
View page or View pdf

EPI System: View
AIDS Citations:Search
Cancer Citations:Search
Toxicology Citations:Search
EPA Substance Registry Services (TSCA):115-71-9
EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
Laboratory Chemical Safety Summary :5368797
National Institute of Allergy and Infectious Diseases:Data
WGK Germany:2
(E)-5-(2,3-dimethyl-4,5,6,7-tetrahydro-1H-tricyclo[2.2.1.02,6]heptan-3-yl)-2-methylpent-2-en-1-ol
Chemidplus:0000115719